Company page

Puma Biotechnology Inc

Puma Biotechnology Inc (PBYI) is a public company based in the United States, focusing on the development and commercialization of innovative cancer therapies. With a market capitalization of approximately $434.2 million, Puma aims to address unmet medical needs in oncology. The company is committed to advancing its pipeline of targeted treatments for patients with various types of cancer.